Sanofi Consumer Healthcare India Share Price
Small Cap | Chemicals | NSE: SANOFICONR | BSE: 544250
₹4,939.60 
-0.40 (-0.01 %)
Last Updated: 02 May 2025 03:55 PM
BULLISH
Overview
Open (₹) 4,938.90
High (₹) 4,953.50
Low (₹) 4,928.10
Prev. Close (₹) 4,940.00
Volume 29,851
VWAP (₹) 4,936.26
ROCE (%) 92.81
Industry P/E 59.39
TTM P/E 62.85
P/B Ratio 41.61
Market Cap (₹) Cr.11,376.21
Dividend Yield (%)1.11
EPS (₹) 78.59
ROE66.21%
Sales Growth (%) 37.89
Profit Growth (%)9.83
Day Range
4,953.504,953.50
52 Week Range
4,360.305,499.00
Historical Returns
Returns (6M)
1.36 %
Returns (1Y)
0.74 %
Returns (3Y)
0.74 %
Returns (5Y)
0.74 %
Returns (6M)
1.36 %
Returns (1Y)
0.74 %
Returns (3Y)
0.74 %
Returns (5Y)
0.74 %
SWOT Analysis
Technicals
Technical Rating
BULLISHRSI 59.90
MFI 81.99
ATR 90.81
Commodity Channel Index 124.58
ROC125 0.74
ROC21 1.24
Williams %R -15.00
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 4,957.04 | 4,975.87 | 5,001.84 | 4,931.07 | 4,912.24 | 4,886.27 | 4,867.44 |
| Week Ago | 4,922.76 | 4,959.33 | 5,005.66 | 4,876.43 | 4,839.86 | 4,793.53 | 4,756.96 |
| Month Ago | 4,846.04 | 4,996.22 | 5,093.74 | 4,748.52 | 4,598.34 | 4,500.82 | 4,350.64 |
EMA & SMA
4939.60
Current Price
Bullish Moving Averages
17
Bearish Moving Averages
1
5 Day 4923.21
9 Day 4866.34
10 Day 4859.99
12 Day 4853.10
14 Day 4838.84
20 Day 4822.84
26 Day 4828.56
50 Day 4766.20
100 Day 4795.94
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 28th Oct, 2024 | Opella Healthcare Participations B.V. | Acquisition | ₹4,781.85 | 4,865 | NSE |
| 28th Oct, 2024 | Sanofi | Disposal | ₹4,781.85 | 4,865 | NSE |
| 14th Oct, 2024 | Opella Healthcare Participations B.V. | Acquisition | ₹4,982.05 | 1,39,04,722 | NSE |
| 14th Oct, 2024 | Hoechst GmbH | Disposal | ₹4,982.05 | 1,39,04,722 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 20th Feb, 2025 | Rs.55.0000 per share(550%)Final Dividend (RD dates revised) | 17th Apr, 2025 | 17th Apr, 2025 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 2nd May, 2025 | BSE India | We wish to inform you that Board of Directors at its meeting today i.e. Friday, 2nd May 2025, inter-alia considered and approved the Unaudited Financial Results for the Quarter ended 31st March 2025. In this regard, please find enclosed a press release. |
| 2nd May, 2025 | BSE India | Board Meeting Outcome for consideration and approval of Unaudited Financial Results for the Quarter ended 31st March 2025 |
| 2nd May, 2025 | BSE India | We refer to our letter dated 25th April 2025 informing you of our Board Meeting that was scheduled today. In this regard, we wish to inform you that the Board of Directors at its meeting held today i.e., Friday, 2nd May 2025, inter-alia considered and approved the Unaudited Financial Results for the quarter ended 31st March 2025. |
| 2nd May, 2025 | BSE India | Citigroup Global Markets India Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 30, 2025. |
| 1st May, 2025 | NSE India | Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated April 30, 2025, titled ""Sanofi and CD&R close Opella transaction, create global consumer healthcare leader"". |
| 1st May, 2025 | BSE India | Sanofi and CD&R close Opella transaction, create global consumer healthcare leader |
| 30th Apr, 2025 | NSE India | Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 29, 2025. |
| 30th Apr, 2025 | BSE India | Citigroup Global Markets India Pvt. Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 29, 2025. |
| 29th Apr, 2025 | NSE India | Sanofi Consumer Healthcare India Limited has informed the Exchange about Closure of Trading Window |
| 26th Apr, 2025 | NSE India | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 02-May-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended March 2025 . |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 28th Apr, 2025 | 2nd May, 2025 |
| Audited Results & Final Dividend | -- | 18th Feb, 2025 | 20th Feb, 2025 |
| Quarterly Results | -- | 6th Nov, 2024 | 12th Nov, 2024 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | |||
|---|---|---|---|---|---|
| Promoter Group | 60.4% | 60.4% | 0% | 0% | 0% |
| Foreign Institutions + | 4.52% | 4.42% | 0% | 0% | 0% |
| Domestic Institutions + | 25.48% | 25.35% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 9.6% | 9.83% | 0% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India is a Public Limited Listed company incorporated on 10/05/2023 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U21002MH2023PLC402652 and registration number is 402652. Currently company belongs to the Industry of Chemicals - Speciality. Company’s Total Operating Revenue is Rs. 724.50 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2024.
Parent Organisation
Not Applicable
Founded
2023
Managing Director
Mr. Himanshu Bakshi
NSE Symbol
SANOFICONR
Sanofi Consumer Healthcare India Management
| Name | Designation |
|---|---|
| Mr. Himanshu Bakshi | Managing Director |
| Mr. Surendra Agarwall | WholeTime Director & CFO |
| Mr. Carol-Ann Stewart | Non Executive Director |
| Mr. Amit Jain | Independent Director |
| Mr. Shobinder Duggal | Independent Director |
| Mr. Suparna Pandhi | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Pidilite Industries | ₹1,53,037.15 | ₹3,008.70  ₹3,033.90(-0.83%) | ₹2,620.150 - ₹3,414.400 |
| Gujarat Fluorochemicals | ₹42,546.00 | ₹3,873.10 ₹3,892.70(-0.50%) | ₹2,480.000 - ₹4,875.000 |
| Apar Industries | ₹22,215.09 | ₹5,530.50 ₹5,603.00(-1.29%) | ₹4,270.000 - ₹11,797.350 |
| Himadri Speciality Chemical | ₹21,279.97 | ₹430.90 ₹437.70(-1.55%) | ₹307.300 - ₹688.500 |
| Aarti Industries | ₹15,466.92 | ₹426.65  ₹421.25(1.28%) | ₹347.350 - ₹767.100 |
FAQs on Sanofi Consumer Healthcare India
What is the share price of Sanofi Consumer Healthcare India?
The share price of Sanofi Consumer Healthcare India on 2nd May, 2025 is ₹ 4,939.60.
What is 52W high and 52W low share price of Sanofi Consumer Healthcare India?
The highest and lowest 52W share prices of Sanofi Consumer Healthcare India are ₹ 5499.000 and ₹ 4360.300
What is the market cap of Sanofi Consumer Healthcare India?
The market capitalization of Sanofi Consumer Healthcare India as of 2nd May, 2025 is ₹ 11,376.21 Crores
What is the P/E ratio of Sanofi Consumer Healthcare India?
The current P/E ratio of Sanofi Consumer Healthcare India as of 2nd May, 2025 is 59.39
What is the PB ratio of Sanofi Consumer Healthcare India?
The PB ratio of Sanofi Consumer Healthcare India as of 2nd May, 2025 is 41.61
Top Gainers
₹14.37
₹11.98 (0.20%)
₹110.78
₹92.32 (0.20%)
₹108.60
₹90.50 (0.20%)
₹150.10
₹125.30 (0.20%)
Top Losers
₹269.00
₹316.50 (-0.15%)
₹392.90
₹436.40 (-0.10%)
₹0.50
₹0.62 (-0.19%)
₹664.60
₹771.65 (-0.14%)
Market Indices
Sensex
₹80,501.99
₹80,242.24 (0.00%)